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SEVERE ANEMIA CAUSED BY BABESIOSIS IN A MANED WOLF
(CHRYSOCYON BRACHYURUS)
Kristen A. Phair, D.V.M., James W. Carpenter, M.S., D.V.M., Dipl. A.C.Z.M., Nicole Smee, D.V.M.,
Carl B. Myers, D.V.M., and Lisa M. Pohlman, D.V.M., M.S., Dipl. A.C.V.P.
Abstract: An 8-yr-old, captive, spayed, female maned wolf (Chrysocyon brachyurus) developed progressive
lethargy and weakness over a 24-hr period. Clinical signs included vomiting, recumbency, horizontal nystagmus,
possible blindness, pale icteric mucus membranes, and port-wine colored urine. A complete blood cell count
revealed severe anemia (packed cell volume [PCV], 6%) and intraerythrocytic piroplasms consistent with a Babesia
species. Polymerase chain reaction testing later confirmed babesiosis. The wolf was treated with imidocarb
dipropionate, antibiotics, and fluid therapy. A whole-blood transfusion from a sibling maned wolf also was
performed. Despite aggressive treatment, the wolf failed to improve and was euthanized. To the authors’
knowledge, this is the first documented case of babesiosis in a captive maned wolf in North America. Surveillance
of infectious diseases in captive and wild maned wolf populations should be expanded to include screening for
Babesia species. Tick control also should be implemented to prevent and decrease transmission of the disease to
this endangered species.
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BRIEF COMMUNICATION
The maned wolf (Chrysocyon brachyurus), an
endangered species, is susceptible to many of the
same canine infectious diseases reported in do-
mestic dogs. Exposure to canine distemper virus,
rabies virus, canine parvovirus, canine adenovi-
rus, Dirofilaria immitis, Ehrlichia canis, Rickettsia
rickettsii, Leptospira interrogans spp., and Toxoplas-
ma gondii has been documented in South Amer-
ican domestic dogs and the wild populations of
maned wolves living close to them.2,6 Captive
populations of maned wolves are at risk for
acquisition of the same infectious diseases from
other canid species within zoo collections and
from domestic dogs that may live in proximity to
zoologic institutions. Canine babesiosis caused by
various species of the genus Babesia has been on
the rise in North America within the past 2
decades1 and should be considered a disease of
potential concern in captive maned wolves.
An 8-yr-old, spayed, female maned wolf devel-
oped progressive lethargy and weakness, with
concurrent reduced appetite and episodes of
vomiting over a 24-hr period. Other than chronic
bilateral hind limb orthopedic problems, the
wolf ’s medical history had been unremarkable.
Preventative care included annual rabies and
canine distemper vaccinations, and monthly
heartworm (ivermectin; Heartgardt, Merial Lim-
ited, Duluth, Georgia 30096, USA) and flea
(lufenuron; Programt, Novartis, Greensboro,
North Carolina 27408, USA) prevention. There
had been no known toxin exposure or dietary
changes. The wolf shared an enclosure with a male
sibling that was showing no abnormalities.
On visual observation, the wolf was sternally
recumbent within its crate and unable to rise. The
wolf made exaggerated head and neck excursions
when attempting to lift its head and had a mild
right head tilt and significant horizontal nystag-
mus. The wolf ’s startled responses to sound and
inability to focus on surrounding activity suggest-
ed that it might be nonvisual. The wolf was
transported to the Kansas State University Vet-
erinary Medical Teaching Hospital for further
evaluation. The wolf was immobilized by injec-
tion with ketamine (1 mg/kg i.m.), medetomidine
(0.015 mg/kg i.m.), and midazolam (0.5 mg/kg
i.m.). Once induced, the wolf was intubated with
an 11-mm endotracheal tube, and anesthesia was
maintained with isoflurane gas (0.5–3.0%) and
oxygen (2 L/min).
On physical examination, the wolf weighed 24 kg
and was in good body condition. Heart rate (85
beats/min), respiratory rate (26 breaths/min), and
temperature (388C) were all within established
reference ranges. Mucus membranes were icteric
and tacky, with a capillary refill time (CRT), 2 sec.
The sclera also were icteric. The abdomen felt
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slightly distended, and, on firm palpation, a large
amount of port-wine–colored urine was expressed.
Distinct organomegaly was not identified on ab-
dominal palpation. Ectoparasites were not found.
A complete blood cell count (CBC) revealed
severe regenerative anemia (packed cell volume
[PCV], 6%; reference range, 34.3–47.5%), a nor-
mal total protein (6.9 g/dl; reference interval, 5.4–
7.0 g/dl), and marked hemolysis.10 A slide agglu-
tination test was negative. There was mild leuko-
penia with mild-moderate lymphopenia (Table 1).
Thrombocytopenia was present, with occasional
large forms. Frequently noted within the erythro-
cytes were 1–2 lm, circular-to-oval intraerythro-
cytic piroplasms consistent with a small Babesia
species. No paired piroplasms were observed.
There also were rare, small, chain-like structures
on erythrocytes, suggestive of possible Mycoplas-
ma hemocanis infection. PCR was recommended
to confirm Babesia infection and to test for
possible M. hemocanis infection. Subsequent RT-
PCR of the blood revealed a strongly positive
result (.500 copies/ml blood) for Babesia canis
canis and/or Babesia canis vogeli (Fluorescence
Resonance Energy Transfer [FRET] real-time
PCR targeting the canine Babesia species 18s
rNA gene, Auburn University, Auburn, Alabama,
USA).12 RT-PCR testing for M. hemocanis was
negative. Later in the course of the disease, a
cerebrospinal fluid tap also was performed. Mi-
croscopic analysis of the fluid was considered
normal. The cerebrospinal fluid was negative for
Rocky Mountain Spotted Fever (immunofluores-
cent assay [IFA] screen) and Cryptococcus (latex
agglutination screen).
A serum chemistry panel revealed an increased
urea nitrogen with a normal creatinine, moderate
hypocalcemia, moderate hypokalemia, and hyper-
bilirubinemia (Table 2). The hypocalcemia was
likely due to an acidotic state. A SNAP 4Dx Test
(Idexx Laboratories, Inc., Westbrook, Maine
04092, USA) was negative for Lyme disease,
ehrlichiosis, heartworm disease, and anaplasmo-
sis. Thoracic and abdominal radiographs were
taken but did not indicate any clinically significant
abnormalities.
Intravenous fluid administration was started
(lactated Ringer’s solution, at 20 ml/kg/hr). An
immunosuppressive dose of dexamethasone SP
(0.28 mg/kg i.v.) was given. Enrofloxacin (5 mg/kg
i.v.; Baytrilt, Bayer Healthcare, Shawnee Mission,
Kansas 66216, USA) and famotidine (0.5 mg/kg
s.c.; Baxter International Inc., Deerfield, Illinois
60015-4634, USA) also were administered to
provide antimicrobial effects and gastrointestinal
protection, respectively. Treatment with imido-
carb dipropionate (6.6 mg/kg, i.m., q. 14 d;
Imizolt, Intervet/Schering-Plough Animal
Health, Worthington, Minnesota 56187, USA)
also was initiated in light of the possible diagnosis
of babesiosis. Once treatments were completed,
atipamezole (2 mg i.m.; Antisedant, Pfizer Ani-
mal Health, New York City, New York 10017,
USA) was given as a reversal agent.
Because recheck PCV 12 hr later remained
unchanged and the wolf was recumbent and
Table 1. Serial complete blood cell count values for a maned wolf with babesiosis.
Complete blood cell count Reference interval10 Admission 12 hr 24 hr 72 hr 6 days 8 days
Leukocytes, cells/ll 6,580–14,360 6,200 48,800 44,600 38,400
Segmented neutrophils, cells/lL 3,669–10,481 5,200 42,000 40,600 33,400
Band neutrophils, cells/ll 0–395 100 0 400 0
Lymphocytes, cells/ll 1,029–3,343 400 2,900 1,300 1,500
Monocytes, cells/ll 0–334 400 3,400 2,200 3,500
Eosinophils, cells/ll 0–617 0 500 0 0
Basophils, cells/ll 0–79 100 0 0 0
Hematocrit, % 34.3–47.5 6 7 16 25 23 9
Hemoglobin, g/dl 11.3–15.9 2.7 8.4 7.6 3.1
Mean cell volume, fl 68.4–83.2 76 74 76 78
Mean cell hemoglobin, pg 23.2–28.2 44 26 25 26
Mean cell hemoglobin
concentration, g/dl
31.1–36.1 59 34 33 34
Platelets, 1,000/ll 145–285 ,10 Mildly
decreased
Adequate Adequate
Total protein, g/dl 5.4–7.0 6.9 6.6 8.1 7.8 5.7
Gross plasma appearance Marked
hemolysis
Icterus Icterus Icterus
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obtunded, a whole-blood transfusion was admin-
istered. The male sibling weighed 26 kg and was
immobilized by using ketamine (1 mg/kg i.m.),
medetomidine (0.02 mg/kg i.m.), and midazolam
(0.3 mg/kg i.m.), intubated, and maintained on
isoflurane and oxygen. A unit of whole blood (450
ml) was collected from the jugular vein by using a
Teruflext closed single bag collection system that
contained CDPA-1 anticoagulant (Terumo Med-
ical Corporation, Elkton, Maryland, 21921-5330,
USA). The maned wolf was reversed with atipa-
mezole (2.6 mg i.m.) and recovered without
complications. A CBC of the donor blood later
showed a normal PCV (39%; reference interval,
34.3–47.5%) and no evidence of parasitemia on
blood film evaluation.
To perform the blood transfusion, the female
wolf was sedated with midazolam (0.45 mg/kg
i.m.) and masked with isoflurane gas and oxygen.
The whole-blood transfusion was given via an 18-
gauge catheter placed in the lateral saphenous
vein over a period of approximately 2 hr. Heart
rate, respiratory rate, temperature, blood pres-
sure, and electrocardiography were monitored
every 5 min during the transfusion, and all
parameters remained stable. After the transfu-
sion, fluids were administered (lactated Ringer’s
solution 700 ml s.c.). At 4 hr after the transfusion,
the wolf ’s PCV and total solids were 16% and 6.6
g/dl, respectively (Table 1).
At 24 hr after transfusion, the wolf ’s attitude
had not improved appreciably, although the
horizontal nystagmus had resolved, and, subjec-
tively, it was thought that the wolf could see.
Dark-red urine was seen in the cage. Treatments
consisted of dexamethasone SP (0.28 mg/kg i.m.,
q. 24 hr), famotidine (0.5 mg/kg s.c., q. 24 hr), and
fluids (lactated Ringer’s solution, 500 ml s.c., q. 12
hr). Oxytetracycline (13.3 mg/kg i.m., q. 24 hr)
administration was started to address the possible
Mycoplasma infection. Syringe feeding with wet
food, and water was attempted but was unsuc-
cessful.
At 48 hr after transfusion, a CBC and chemistry
panel were repeated. The CBC revealed a PCV of
25%, a marked leukocytosis, with a mature
neutrophilia likely due to a combination of
chronic inflammation and the effects of steroids
and mildly decreased platelets (Table 1). On
blood film examination, very rare ring-shaped
organisms were seen on the erythrocytes. The
serum chemistry panel indicated continued hy-
perbilirubinemia and elevated liver enzymes (Ta-
ble 2). Ionized calcium was mildly low (4.4 mg/dl;
reference interval, 4.55–5.77 mg/dl). Six days
after presentation, the wolf ate a small quantity
on its own. The wolf stood but exhibited marked
ataxia and weakness. Urination and defecation
were noted. A CBC was rechecked, and the
abnormalities were similar to the previous assess-
ment (Table 1). Eight days after presentation, the
Table 2. Serial serum chemistry values from a maned wolf with babesiosis.
Serum chemistry Reference intervala Admission 72 hr 8 days
Glucose, mg/dl 90–140 112 149 285
Urea nitrogen, mg/dl 14–32 64 14 68
Creatinine, mg/dl 0.9–1.7 1.4 0.8 3.7
Total protein, g/dl 5.4–7.0 6.8 6.8 4.7
Albumin, g/dl 2.7–3.5 2.4 2.6 2.1
Calculated globulin, g/dl 2.4–3.8 4.4 4.2 2.6
Total calcium, mg/dl 9.1–10.5 7.9 8.1 8.3
Phosphorus, mg/dl 3.3–8.5 5.7 4.4 7.1
Sodium, mmol/L 141–149 144 145 145
Potassium, mmol/L 4.3–5.3 2.5 2.8 4.9
Chloride, mmol/L 110–118 112 114 109
Bicarbonate, mmol/L 18–29b 14 16 11
Alanine transaminase, U/L 28–171b 73 676 1,047
Alkaline phosphatase, U/L 1–142b NVc 465 635
Creatine kinase, U/L 128–328b 548 7,386 1,373
Total bilirubin, mg/dl 0.1–0.3b 5.5 6.1 3.0
Cholesterol, mg/dl 203–571 228 220 84
Serum appearance Marked hemolysis Marked icterus Icterus
a Reference intervals from Kennedy-Stoskopf,10 unless otherwise indicated.
b Domestic dog reference intervals from the Kansas State University Veterinary Diagnostic Laboratory.
c No value due to marked hemolysis.
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wolf ’s condition deteriorated. Its PCV decreased
to 9%, and it was completely anorexic and
hypothermic (378C), and exhibited severe obtun-
dation. Given the wolf ’s very poor response to
treatment and visible suffering, euthanasia was
elected. Blood for a CBC and chemistry panel was
collected just before euthanasia (Tables 1, 2).
On postmortem examination, the wolf was in
good body condition, with adequate internal fat
stores. The mucus membranes and skin were pale
and yellow. The liver was diffusely yellow to green
in color, and the serosa of the gallbladder had
multiple hemorrhages. The spleen appeared
grossly normal. Bilaterally, there were dark-red
linear tracts that extended from the cortex to the
medulla in the kidneys. The renal cortices were
dark red to brown. The urinary bladder was
contracted, and the urine was dark brown. The
left coxofemoral joint was luxated, and the left
femoral head had undergone extensive remodel-
ing, with flattening of the articular surface and
abundant proliferative bone at the base of the
head and neck. The acetabulum was shallow, with
circumferential proliferative bone.
On histopathologic examination, the centrilob-
ular and midzonal hepatocytes had markedly
vacuolated cytoplasm. The gallbladder had a
moderate amount of hemorrhage within the
adventitial layer. Within the left ventricle of the
heart, there was a focal area of degenerate and
necrotic cardiomyocytes, with infiltration by small
numbers of macrophages and increased numbers
of fibroblasts. Within the kidneys, approximately
50% of the cortical tubules were dilated, and there
was occasional tubular epithelial regeneration.
Approximately 20% of the cortical and medullary
tubules contained bile. Depressed areas of the
cortex corresponded to areas of tubular atrophy,
with intratubular deposition of red granular
material (hemoglobin).These histopathologic
findings were consistent with marked hepatocyte
degeneration and bile stasis; moderate diffuse
serosal hemorrhage of the gallbladder; focal
cardiomyocyte degeneration and necrosis; multi-
focal renal tubular epithelial degeneration, loss,
and regeneration, with multifocal areas of tubular
loss and hemoglobin casts; chronic luxation and
bony remodeling of the left coxofemoral joint;
and severe icterus.
Canine babesiosis is a tick-borne infectious
disease caused by the protozoal genus Babesia.
There currently are 4 species of Babesia that are
known to infect canids within North America: B.
canis, Babesia gibsoni, Babesia conradae, and a yet
unnamed North Carolina Babesia species.1,8 To
the authors’ knowledge, this is the first docu-
mented case of canine babesiosis in a captive
maned wolf in North America. Babesiosis has
previously been found in captive maned wolves in
South America5 and in other canid species, such
as the red fox (Vulpes vulpes), and has been
experimentally induced in coyotes (Canis la-
trans).3,7,11
Transmission of Babesia species is typically
through the bite of a tick vector; however, other
forms of hematogenous horizontal and vertical
transmission may be possible.8 Once inside a new
host, the protozoa enters the red blood cell. The
intraerythrocytic protozoa leads to erythrocyte
destruction by two mechanisms: erythrocyte fra-
gility is increased, predisposing the cell to lysis,
and antibody deposition on the surface of the
infected erythrocytes targets the cells for destruc-
tion by the immune system.1
Babesia infections may be subclinical, acute, or
chronic in nature.8 Clinical signs of babesiosis are
variable, depending on the particular Babesia
species and the nature of the infection. Clinical
signs can include depression, weakness, anorexia,
pallor, anemia, thrombocytopenia, and vomiting.
Splenomegaly may be identified on physical
examination and necropsy. Uncomplicated babe-
siosis cases may have any of the previous abnor-
malities, whereas, complicated babesiosis may
result in secondary systemic effects, such as
cardiovascular, respiratory, hepatic, renal, gastro-
intestinal, neurologic, and coagulopathic dysfunc-
tion.1 One study found that central nervous
system involvement in canine Babesia canis rossi
cases in South Africa increased the risk of death
by 57 times.9 In this particular case, we suspect
that the maned wolf had a complicated form of
babesiosis as evidenced by her neurologic signs,
hepatopathy, and renal abnormalities. The char-
acteristic splenomegaly of babesiosis was not
identified on physical examination or necropsy.
Diagnosis can be made by visualizing charac-
teristic intraerythrocytic organisms on blood
smears. However, this method does not allow
definitive species identification. The current di-
agnostic method of choice for both diagnosis and
speciation of Babesia is PCR testing.1,8 In the
present case, morphologic appearance on the
blood film and PCR seemed contradictory. Based
upon the small size and signet-ring shape of the
intraerythrocytic parasite seen on blood smear, it
was thought that a small Babesia species (such as
B. gibsoni) was the causative agent. The paired
piroplasms characteristic of B. canis were not
seen. However, FRET-PCR testing identified B.
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canis within the blood sample, which is a large
Babesia species. Interestingly, in addition to the
unambiguous melting curve of Babesia canis canis
(or B. canis vogeli), with a peak at a melting
temperature (Tm) of about 608C,12 there also was
a small secondary peak identified with a Tm of
about 678C, higher than the Tm of 648C that
would be expected for B. gibsoni. The higher Tm of
this second peak could indicate that the probe had
a perfect match with the target sequence, which
could further indicate an as yet undescribed
Babesia species (Kaltenboeck, pers. comm.). Un-
fortunately, it was determined that sequencing
would not help with identification because of the
mixture of amplification products. Only cloning
of the products and sequencing many of them
would give the precise sequence and the relative
proportions of this sequence among the B. canis
sequences. Cloning was not performed in this
cased due to a lack of an appropriate sample.
Whereas B. gibsoni is the most common cause of
canine babesiosis in the United States1,12 and was
thought to be the most likely Babesia species in
this case based on blood smear evaluation, FRET-
PCR testing identified B. canis canis and/or B. canis
vogeli and a possible novel Babesia species as the
causative agent(s).
Treatment of babesiosis typically consists of
two intramuscular injections of imidocarb dipro-
pionate, separated by 2 wk. Other drug options
exist, such as diminazene aceturate or a combi-
nation of atovaquone and azithromycin, but these
are not currently approved in the United States.
Other important aspects of therapy include fluid
support, blood transfusions if severe anemia is
present, and immunosuppressants if a component
of immune-mediated hemolytic anemia is sus-
pected. The maned wolf in this case received a
whole-blood transfusion from her male sibling.
The transfusion approach taken differed from an
ideal method because a blood type and cross
match were not performed before transfusion.
Due to time constraints, lack of other readily
feasible treatment options, and the presence of a
sibling wolf for blood donation, the decision was
made to proceed with the transfusion despite the
risks (including the possibility that the donor also
could be positive for Babesia or other pathogens).
Immunosuppressant administration also was
started because there was a high degree of
suspicion that an immune-mediated process was
contributing to the wolf ’s critically low hemato-
crit. However, there also was substantial concern
that an immunosuppressant would weaken the
wolf ’s ability to clear the hemoprotozoa.
Prognosis for canine babesiosis is largely based
upon degree of complication and response to
treatment. Unfortunately, the maned wolf in this
case failed to make substantial improvement
during the course of treatment. The lack of
noticeable clinical improvement after the blood
transfusion and the increased hematocrit were
most concerning and may have been indicators of
other systemic complications. Prevention of bab-
esiosis is best accomplished by preventing tick
attachment to the host. The tick vector has to be
attached for 2 to 3 days for transmission of
Babesia to occur, so, frequent screening for ticks
and rapid removal may help prevent the disease.1
In domestic animals, topical anti-tick medications
and tick collars can be used to keep ticks away.
However, in zoo and wildlife species, both these
prevention methods are problematic and not
necessarily practical.
This case demonstrates that captive maned wolf
populations in North America are at risk for
babesiosis and provides a readily accessible docu-
mentation of this disease process in the maned
wolf. Canine babesiosis has been documented in
domestic dog populations and in captive maned
wolves in Brazil.4,5,11 Wild and captive populations
of maned wolves that live in proximity to domestic
dogs may be at risk for Babesia infection. Surveil-
lance of infectious diseases in captive and wild
maned wolf populations should be expanded to
include screening for Babesia species. Tick control
also should be considered and implemented to
prevent and decrease transmission of the disease to
this endangered species.
Acknowledgments: The authors would like to
acknowledge Dr. Kenneth Harkin for his tremen-
dous assistance with this case, the Sunset Zoo
staff for their support and care, and Dr. Bernhard
Kaltenboeck for his interpretation of the Babesia
FRET-PCR data.
LITERATURE CITED
1. Ayoob, A. L., S. G. Hackner, and J. Prittie. 2010.
Clinical management of canine babesiosis. J. Vet.
Emerg. Crit. Care 20: 77–89.
2. Bronson, E., L. H. Emmons, S. Murray, E. J.
Dubovi, and S. L. Deem. 2008. Serosurvey of patho-
gens in domestic dogs on the border of Noel Kempff
Mercado National Park, Bolivia. J. Zoo Wildl. Med.
39: 28–36.
3. Clancey, N., B. Horney, S. Burton, A. Birkenheuer,
S. McBurney, and K. Tefft. 2010. Babesia (Theileria)
annae in a red fox (Vulpes vulpes) from Prince Edward
Island, Canada. J. Wildl. Dis. 46: 615–621.
166 JOURNAL OF ZOO AND WILDLIFE MEDICINE
4. Costa-Junior, L. M., M. F. Ribeiro, K. Rembeck,
E. M. Rabelo, M. Zahler-Rinder, J. Hirzmann, K.
Pfister, and L. M. Passos. 2009. Canine babesiosis
caused by Babesia canis vogeli in rural areas of the State
of Minas Gerais, Brazil and factors associated with its
seroprevalence. Res. Vet. Sci. 86: 257–260.
5. Cubas, Z. S. 1996. Special challenges of maintain-
ing wild animals in captivity in South America. Rev.
Sci. Tech. 15:267–287.
6. Deem, S. L., and L. H. Emmons. 2005. Exposure
of free-ranging maned wolves (Chrysocyon brachyurus)
to infectious and parasitic disease agents in the Noel
Kempff Mercado National Park, Bolivia. J. Zoo Wildl.
Med. 36: 192–197.
7. Evers, H. V., A. A. Kocan, M. V. Reichard, and J.
H. Meinkot. 2003. Experimental Babesia gibsoni infec-
tion in coyotes (Canis latrans). J. Wildl. Dis. 39: 904–908.
8. Holman, P. J., and K. F. Snowden. 2009. Canine
hepatozoonosis and babesiosis, and feline cytauxzoo-
nosis. Vet. Clin. Small Anim. 39: 1035–1053.
9. Jacobson, L. S. 2006. The South African form of
severe and complicated canine babesiosis: clinical
advances 1994–2004. Vet. Parasitol. 138: 126–139.
10. Kennedy-Stoskopf, S. 2003. Canidae. In: Fowler,
M. E., and R. E. Miller (eds.). Zoo and Wild Animal
Medicine, 5th ed. W. B. Saunders Co., Philadelphia,
Pennsylvania. Pp. 482–491.
11. O’Dwyer, L. H., V. V. Lopes, A. S. Rubini, S.
Paduan Kdos, and P. E. Ribolla. 2009. Babesia spp.
infection in dogs from rural areas of Sa˜o Paulo State,
Brazil. Rev. Bras. Parsitol. Vet. 18: 23–26.
12. Wang, C., S. K. Ahluwalia, Y. Li, D. Gao, A.
Poudel, E. Chowdhury, M. K. Boudreaux, and B.
Kaltenboeck. 2010. Frequency and therapy monitoring
of canine Babesia spp. infection by high-resolution
melting curve quantitative FRET-PCR. Vet. Parasitol.
168:11–18.
Received for publication 19 November 2010
PHAIR ET AL.—BABESIA IN MANED WOLF 167
